These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
763 related articles for article (PubMed ID: 30916406)
21. Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma. Chen R; Chen Y; Huang W; Zhao Y; Luo W; Lin J; Wang Z; Yang J Aging (Albany NY); 2021 Jul; 13(13):17607-17628. PubMed ID: 34237706 [TBL] [Abstract][Full Text] [Related]
22. Five lncRNAs associated with the survival of hepatocellular carcinoma: a comprehensive study based on WGCNA and competing endogenous RNA network. Liu DH; Wang SL; Hua Y; Shi GD; Qiao JH; Wei H Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7621-7633. PubMed ID: 32744688 [TBL] [Abstract][Full Text] [Related]
23. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
24. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249 [TBL] [Abstract][Full Text] [Related]
25. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma. Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177 [TBL] [Abstract][Full Text] [Related]
26. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma. Chen QF; Huang T; Si-Tu QJ; Wu P; Shen L; Li W; Huang Z J Cell Biochem; 2020 Mar; 121(3):2303-2317. PubMed ID: 31642123 [TBL] [Abstract][Full Text] [Related]
27. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma. Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185 [TBL] [Abstract][Full Text] [Related]
28. Construction and Analysis of lncRNA-Mediated ceRNA Network in Nasopharyngeal Carcinoma Based on Weighted Correlation Network Analysis. Zou Z; Liu S; Ha Y; Huang B Biomed Res Int; 2020; 2020():1468980. PubMed ID: 33102573 [TBL] [Abstract][Full Text] [Related]
29. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma. Zhou D; Gao B; Yang Q; Kong Y; Wang W Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187 [TBL] [Abstract][Full Text] [Related]
30. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma. Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models. Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer. Tuersong T; Li L; Abulaiti Z; Feng S Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma. Song W; Miao DL; Chen L Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735 [TBL] [Abstract][Full Text] [Related]
34. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer. Qi M; Yu B; Yu H; Li F Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354 [TBL] [Abstract][Full Text] [Related]
35. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma. Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375 [TBL] [Abstract][Full Text] [Related]
36. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma. Lou X; Li J; Yu D; Wei YQ; Feng S; Sun JJ Cancer Med; 2019 Sep; 8(12):5735-5749. PubMed ID: 31392826 [TBL] [Abstract][Full Text] [Related]
38. Six long noncoding RNAs as potentially biomarkers involved in competitive endogenous RNA of hepatocellular carcinoma. Qu L; Cai X; Xu J; Wei X; Qu X; Sun L; Gong L; Su C; Zhu Y Clin Exp Med; 2020 Aug; 20(3):437-447. PubMed ID: 32514710 [TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008 [TBL] [Abstract][Full Text] [Related]
40. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]